METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
Matthew Albert,Armanda Casrouge,Jeremie Decalf,Stanislas Pol,Arnaud Fontanet,Mostafa Mohamed
申请号：
US13354458
公开号：
US20120171158A1
申请日:
2012.01.20
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to methods for the treatment of infection, a disease, or a condition using CD26 (DPIV) inhibitors. The present invention also relates to an antibody that binds to the IP-10 protein and a method of monitoring the necessity for administering a CD26 inhibitor to a patient, comprising evaluating a level of sIP-10, a activity of CD26, and/or a level of CXCR3 cells in a sample.
